Literature DB >> 11242203

Prevalence and predictive value of overweight in an urban HIV care clinic.

J Shuter1, C J Chang, R S Klein.   

Abstract

OBJECTIVE: To determine the prevalence and predictive value of overweight in an urban HIV clinic.
METHODS: Medical records of all new adult, nonpregnant registrants in 1996 in an urban HIV clinic with at least one height and weight measurement were reviewed. Body mass index (BMI) at clinic enrollment was calculated, and prevalence of overweight was thus determined. The subsequent clinical course of the overweight group was compared with that of a randomly selected group of gender-stratified non-overweight patients.
RESULTS: At baseline, 12.6% of men and 32.5% of women were overweight. Female gender and lack of AIDS diagnosis were independently associated with overweight. More than one half of women and 19.6% of men were overweight at some point during the study. Providers were more likely to properly acknowledge underweight than overweight. Among patients without AIDS, there was a trend toward slower disease progression and lower viral load in overweight patients, despite similar baseline CD4+ lymphocyte counts and similar time to initiation of highly active antiretroviral therapy. In multivariate proportional hazards analyses, lower baseline BMI and falling BMI during follow-up were independently predictive of progression to AIDS.
CONCLUSIONS: Overweight was a common and underrecognized finding, particularly among women. Overweight patients may progress more slowly to AIDS than non-overweight patients.

Entities:  

Mesh:

Year:  2001        PMID: 11242203     DOI: 10.1097/00042560-200103010-00013

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  24 in total

1.  Body mass index and risk of tuberculosis and death.

Authors:  Colleen F Hanrahan; Jonathan E Golub; Lerato Mohapi; Nkeko Tshabangu; Tebogo Modisenyane; Richard E Chaisson; Glenda E Gray; James A McIntyre; Neil A Martinson
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

2.  Brief Report: Circulating Markers of Immunologic Activity Reflect Adiposity in Persons With HIV on Antiretroviral Therapy.

Authors:  John R Koethe; Cathy A Jenkins; Briana D Furch; Jordan E Lake; Louise Barnett; Cindy C Hager; Rita Smith; Todd Hulgan; Bryan E Shepherd; Spyros A Kalams
Journal:  J Acquir Immune Defic Syndr       Date:  2018-09-01       Impact factor: 3.731

3.  An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy.

Authors:  John R Koethe; Cathy A Jenkins; Bryan E Shepherd; Samuel E Stinnette; Timothy R Sterling
Journal:  Clin Infect Dis       Date:  2011-09-26       Impact factor: 9.079

4.  Changes in Body Mass Index Following HAART Initiation among HIV-Infected Women in the Women's Interagency HIV Study.

Authors:  Anjali Sharma; Shalanda A Bynum; Michael F Schneider; Christopher Cox; Phyllis C Tien; Ronald C Hershow; Deborah Gustafson; Michael W Plankey
Journal:  J AIDS Clin Res       Date:  2014

5.  Prevalence and Risk Factors for Overweight and Obesity among HIV-Infected Adults in Dar es Salaam, Tanzania.

Authors:  Helen Semu; Rachel M Zack; Enju Liu; Ellen Hertzmark; Donna Spiegelman; Kevin Sztam; Claudia Hawkins; Guerino Chalamila; Aisa Muya; Hellen Siril; Ramadhani Mwiru; Deo Mtasiwa; Wafaie Fawzi
Journal:  J Int Assoc Provid AIDS Care       Date:  2014-08-21

6.  Comparative Outcomes of Bariatric Surgery in Patients With and Without Human Immunodeficiency Virus.

Authors:  Gautam Sharma; Andrew T Strong; Mena Boules; Chao Tu; Samuel Szomstein; Raul Rosenthal; John Rodriguez; Alan J Taege; Matthew Kroh
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

7.  Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South Africa.

Authors:  Alana T Brennan; Kaitlyn M Berry; Sydney Rosen; Andrew Stokes; Nigel J Crowther; Jaya George; Frederick Raal; Naseem Cassim; Ian Sanne; Lawrence Long; Matthew P Fox
Journal:  AIDS       Date:  2019-11-01       Impact factor: 4.177

8.  Prevalence of obesity and its relationship to clinical lipodystrophy in HIV-infected adults on anti-retroviral therapy.

Authors:  P Freitas; D Carvalho; A C Santos; M J Matos; A J Madureira; R Marques; E Martinez; A Sarmento; J L Medina
Journal:  J Endocrinol Invest       Date:  2011-12-16       Impact factor: 4.256

9.  Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana.

Authors:  S S Martinez; A Campa; H Bussmann; S Moyo; J Makhema; F G Huffman; O D Williams; M Essex; R Marlink; M K Baum
Journal:  Br J Nutr       Date:  2016-04-18       Impact factor: 3.718

10.  Body mass index, immune status, and virological control in HIV-infected men who have sex with men.

Authors:  Aaron J Blashill; Kenneth H Mayer; Heidi M Crane; Chris Grasso; Steven A Safren
Journal:  J Int Assoc Provid AIDS Care       Date:  2013-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.